Cytokinetics, Incorporated (CYTK)
NASDAQ: CYTK · Real-Time Price · USD
62.42
+2.01 (3.33%)
At close: Mar 9, 2026, 4:00 PM EDT
61.46
-0.96 (-1.54%)
After-hours: Mar 9, 2026, 7:37 PM EDT
Cytokinetics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Net Income | -784.96 | -589.53 | -526.24 | -388.96 | -215.31 | |
| Depreciation & Amortization | 10.13 | 9.53 | 11.89 | 5.81 | 2.28 | |
| Loss (Gain) From Sale of Assets | - | 0.05 | - | - | - | |
| Asset Writedown & Restructuring Costs | - | - | - | - | 2.84 | |
| Loss (Gain) From Sale of Investments | -0.03 | -0.02 | 0.04 | 0.11 | - | |
| Stock-Based Compensation | 112.29 | 97.84 | 72.07 | 47.85 | 26.83 | |
| Other Operating Activities | 188.19 | 50.58 | 24.83 | 60.37 | 32.38 | |
| Change in Accounts Receivable | -1.11 | -15.37 | -1.14 | 56.67 | -47.4 | |
| Change in Accounts Payable | 2.66 | -4.48 | -3.48 | 4.52 | 1.06 | |
| Change in Unearned Revenue | -50.76 | 52.37 | - | -87 | - | |
| Change in Other Net Operating Assets | 13.58 | 3.14 | 7.71 | 1.1 | 54.8 | |
| Operating Cash Flow | -510.01 | -395.89 | -414.33 | -299.52 | -142.52 | |
| Capital Expenditures | -24.81 | -3.91 | -1.42 | -11.34 | -48.87 | |
| Investment in Securities | 41.47 | -549.19 | 240.67 | -250.8 | -98.91 | |
| Investing Cash Flow | 16.67 | -553.1 | 239.25 | -262.13 | -147.78 | |
| Long-Term Debt Issued | 729.46 | - | - | 523.59 | - | |
| Long-Term Debt Repaid | -413.51 | -9.62 | -0.86 | -188.93 | - | |
| Net Debt Issued (Repaid) | 315.95 | -9.62 | -0.86 | 334.66 | - | |
| Issuance of Common Stock | 35.98 | 759.86 | 182.69 | 17.54 | 324.85 | |
| Repurchase of Common Stock | -2.47 | -19.63 | -10.52 | -9.6 | -4.87 | |
| Other Financing Activities | 175 | 200 | 50 | 173.56 | - | |
| Financing Cash Flow | 524.46 | 930.61 | 221.32 | 516.17 | 319.98 | |
| Foreign Exchange Rate Adjustments | -0.72 | 0.21 | -0.02 | - | - | |
| Net Cash Flow | 30.4 | -18.17 | 46.22 | -45.48 | 29.68 | |
| Free Cash Flow | -534.82 | -399.8 | -415.75 | -310.85 | -191.39 | |
| Free Cash Flow Margin | -607.48% | -2164.10% | -5521.23% | -328.64% | -271.76% | |
| Free Cash Flow Per Share | -4.45 | -3.57 | -4.31 | -3.46 | -2.49 | |
| Cash Interest Paid | 22.91 | 25.97 | 10.3 | 15.17 | 9.18 | |
| Levered Free Cash Flow | -379.62 | -241.29 | -260.37 | -127.01 | -179.83 | |
| Unlevered Free Cash Flow | -314.7 | -187.22 | -224.33 | -95.04 | -161.5 | |
| Change in Working Capital | -35.63 | 35.66 | 3.09 | -24.7 | 8.46 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.